Search Results - Anurag Relan
- Showing 1 - 4 results of 4
-
1
-
2
-
3
Interim analysis: Open-label extension study of leniolisib for patients with APDS by V. Koneti Rao, Elaine Kulm, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina, Virgil A. S. H. Dalm, Antonino Trizzino, Yulia Zharankova, Sharon Webster, Alanvin Orpia, Julia Körholz, Vassilios Lougaris, Yulia Rodina, Kath Radford, Jason Bradt, Anurag Relan, Steven M. Holland, Michael J. Lenardo, Gulbu Uzel
Published 2023Artigo -
4
A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome by V. Koneti Rao, Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina, Niall Conlon, Tanya Coulter, Virgil A. S. H. Dalm, Antonino Trizzino, Yulia Zharankova, Elaine Kulm, Julia Körholz, Vassilios Lougaris, Yulia Rodina, Kath Radford, Jason Bradt, Klaus Kucher, Anurag Relan, Steven M. Holland, Michael J. Lenardo, Gülbû Uzel
Published 2022Artigo
Search Tools:
Related Subjects
Immunology
Internal medicine
Medicine
Alternative medicine
Gastroenterology
Pathology
Placebo
Adverse effect
Angioedema
Hereditary angioedema
Biochemistry
Bradykinin
C1-inhibitor
Chemistry
Clinical endpoint
Clinical trial
Coagulation
D-dimer
Enzyme
Factor XII
Immune dysregulation
Immune system
Interim analysis
Kallikrein
Pediatrics
Receptor
Saline
Thrombosis